DB
Dilipkumar Bhogilal Shah
About Dilipkumar Bhogilal Shah
Data last updated:
Dilipkumar Bhogilal Shah is a Ceo at Medico Intercontinental Limited (since 2019), Director at Azillian Healthcare Private Limited (since 2019) and Director at Ritz Formulations Private Limited (since 2019), and holds 4 more current directorships. The companies operate in Pharma, Travel and Hospitality and Real Estate and Construction. The 3 current companies with reported revenue have a combined latest revenue of ₹122 Cr; the largest is Medico Intercontinental Limited at ₹96.37 Cr (FY 2025). Earlier, Dilipkumar Bhogilal Shah was a Director at Csk Market Services Private Limited (2009–2015) and Director at Ace Invest Private Limited (2015–2021) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Ceo | 29 May 2019 | 1984 | ₹96.37 Cr (FY 2025) | Active | |
| Director | 08 Apr 2019 | 2005 | ₹18.95 Cr (FY 2025) | Active | |
| Director | 21 Jan 2019 | 2019 | ₹6.24 Cr (FY 2025) | Active | |
| Director | 28 May 2019 | 2012 | Active | ||
| Designated Partner | 17 Jun 2020 | 2020 | Active | ||
| Director | 22 Apr 2019 | 2009 | Active | ||
| Director | 15 May 2017 | 2017 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 May 2009 | 2005 | ₹4.84 Cr (FY 2025) | Active | |
| Director | 04 Feb 2015 | 2013 | ₹2.03 Cr (FY 2025) | Active | |
| Director | 21 Jun 2004 | 2004 | ₹577 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Dilipkumar Bhogilal Shah
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dilipkumar Bhogilal Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dilipkumar Bhogilal Shah
Dilipkumar Bhogilal Shah currently holds 7 directorships: Medico Intercontinental Limited (Ceo, since 29 May 2019, revenue ₹96.37 Cr (FY 2025)); Azillian Healthcare Private Limited (Director, since 08 Apr 2019, revenue ₹18.95 Cr (FY 2025)); Ritz Formulations Private Limited (Director, since 21 Jan 2019, revenue ₹6.24 Cr (FY 2025)); Kingston Club & Spa Private Limited (Director, since 28 May 2019); Kings Marvela Llp (Designated Partner, since 17 Jun 2020); and 2 more.
Dilipkumar Bhogilal Shah was first appointed on 21 Jun 2004 as Director at Acme Formulation Private Limited. The most recent appointment on record is 17 Jun 2020 at Kings Marvela Llp.
The 3 current companies of Dilipkumar Bhogilal Shah that report revenue have a combined latest revenue of ₹122 Cr: Medico Intercontinental Limited ₹96.37 Cr (FY 2025); Azillian Healthcare Private Limited ₹18.95 Cr (FY 2025); Ritz Formulations Private Limited ₹6.24 Cr (FY 2025).
Dilipkumar Bhogilal Shah held 3 earlier board appointments: Csk Market Services Private Limited (Director, 01 May 2009 to 07 Dec 2015); Ace Invest Private Limited (Director, 04 Feb 2015 to 30 Sep 2021); Acme Formulation Private Limited (Director, 21 Jun 2004 to 18 Oct 2012).
The current boards of Dilipkumar Bhogilal Shah's companies include Ankur Amiram Dave (Medico Intercontinental Limited), Jay Sharadkumar Shah (Medico Intercontinental Limited), Parshwa Kaushal Shah (Medico Intercontinental Limited), Priyank Lalitbhai Sancheti (Medico Intercontinental Limited), Puneeta Sharma (Medico Intercontinental Limited), Samir Dilipkumar Shah (Medico Intercontinental Limited), among others.